| Clinical relevance of biomarkers of oxidative stress J Frijhoff, PG Winyard, N Zarkovic, SS Davies, R Stocker, D Cheng, ... Antioxidants & redox signaling 23 (14), 1144-1170, 2015 | 984 | 2015 |
| Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini Free radical research 47 (sup1), 3-27, 2013 | 966 | 2013 |
| Chemistry and biochemistry of lipid peroxidation products F Guéraud, M Atalay, N Bresgen, A Cipak, PM Eckl, L Huc, I Jouanin, ... Free radical research 44 (10), 1098-1124, 2010 | 661 | 2010 |
| Natural and synthetic antioxidants: an updated overview A Augustyniak, G Bartosz, A Čipak, G Duburs, LU Horáková, W Łuczaj, ... Free radical research 44 (10), 1216-1262, 2010 | 399 | 2010 |
| Short overview of ROS as cell function regulators and their implications in therapy concepts L Milkovic, A Cipak Gasparovic, M Cindric, PA Mouthuy, N Zarkovic Cells 8 (8), 793, 2019 | 330 | 2019 |
| Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets J Kopecka, P Trouillas, AČ Gašparović, E Gazzano, YG Assaraf, C Riganti Drug Resistance Updates 49, 100670, 2020 | 229 | 2020 |
| Biocompatibility of implantable materials: an oxidative stress viewpoint PA Mouthuy, SJB Snelling, SG Dakin, L Milković, AČ Gašparović, AJ Carr, ... Biomaterials 109, 55-68, 2016 | 217 | 2016 |
| Pathophysiological relevance of aldehydic protein modifications N Zarkovic, A Cipak, M Jaganjac, S Borovic, K Zarkovic Journal of proteomics 92, 239-247, 2013 | 200 | 2013 |
| Anticancer and antioxidative effects of micronized zeolite clinoptilolite. N Zarkovic, K Zarkovic, M Kralj, S Borovic, S Sabolovic, MP Blazi, A Cipak, ... Anticancer research 23 (2B), 1589-1595, 2003 | 184 | 2003 |
| Biomarkers of oxidative and nitro‐oxidative stress: conventional and novel approaches A Cipak Gasparovic, N Zarkovic, K Zarkovic, K Semen, D Kaminskyy, ... British journal of pharmacology 174 (12), 1771-1783, 2017 | 126 | 2017 |
| An Overview on Anticancer Activities of the Viscum Album Extract Isorel® N Zarkovic, T Vukovic, I Loncaric, M Miletic, K Zarkovic, S Borovic, A Cipak, ... Cancer Biotherapy and Radiopharmaceuticals 16 (1), 55-62, 2001 | 110 | 2001 |
| Assays for the measurement of lipid peroxidation AC Gasparovic, M Jaganjac, B Mihaljevic, SB Sunjic, N Zarkovic Cell senescence: Methods and protocols, 283-296, 2013 | 100 | 2013 |
| Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor L Milkovic, A Cipak Gasparovic, N Zarkovic Free Radical Research 49 (7), 850-860, 2015 | 94 | 2015 |
| Selected attributes of polyphenols in targeting oxidative stress in cancer V Stepanic, AC Gasparovic, KG Troselj, D Amic, N Zarkovic Current topics in medicinal chemistry 15 (5), 496-509, 2015 | 84 | 2015 |
| Pathophysiology of neutrophil-mediated extracellular redox reactions M Jaganjac, A Cipak, RJ Schaur, N Zarkovic Front Biosci (Landmark Ed) 21 (4), 839-855, 2016 | 83 | 2016 |
| Rat aquaporin-5 is pH-gated induced by phosphorylation and is implicated in oxidative stress C Rodrigues, AF Mósca, AP Martins, T Nobre, C Prista, F Antunes, ... International journal of molecular sciences 17 (12), 2090, 2016 | 81 | 2016 |
| Cancer growth regulation by 4-hydroxynonenal AC Gasparovic, L Milkovic, SB Sunjic, N Zarkovic Free Radical Biology and Medicine 111, 226-234, 2017 | 76 | 2017 |
| What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg T Alexa-Stratulat, M Pešić, AČ Gašparović, IP Trougakos, C Riganti Drug resistance updates 46, 100643, 2019 | 75 | 2019 |
| Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers S Gveric-Ahmetasevic, SB Sunjic, H Skala, L Andrisic, M Stroser, ... Free radical research 43 (4), 376-384, 2009 | 73 | 2009 |
| The influence of Isorel on the advanced colorectal cancer M Cazacu, T Oniu, C Lungoci, A Mihailov, A Cipak, R Klinger, T Weiss, ... Cancer Biotherapy and Radiopharmaceuticals 18 (1), 27-34, 2003 | 73 | 2003 |
